PIANTONI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.997
EU - Europa 1.088
AS - Asia 1.014
SA - Sud America 206
AF - Africa 28
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.340
Nazione #
US - Stati Uniti d'America 1.956
SG - Singapore 411
CN - Cina 255
DE - Germania 213
IT - Italia 205
BR - Brasile 183
PL - Polonia 137
HK - Hong Kong 136
FI - Finlandia 119
UA - Ucraina 94
GB - Regno Unito 78
VN - Vietnam 72
RU - Federazione Russa 60
FR - Francia 40
TR - Turchia 37
SE - Svezia 32
IE - Irlanda 31
CA - Canada 24
NL - Olanda 20
BD - Bangladesh 18
IN - India 17
ZA - Sudafrica 12
JP - Giappone 11
AT - Austria 9
ES - Italia 9
IQ - Iraq 9
MX - Messico 9
AR - Argentina 8
MK - Macedonia 7
BE - Belgio 6
GR - Grecia 6
ID - Indonesia 6
KR - Corea 6
CZ - Repubblica Ceca 5
MA - Marocco 5
PK - Pakistan 5
AU - Australia 4
AZ - Azerbaigian 4
EG - Egitto 4
KE - Kenya 4
PT - Portogallo 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CO - Colombia 3
JO - Giordania 3
LT - Lituania 3
PH - Filippine 3
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EU - Europa 2
IL - Israele 2
KZ - Kazakistan 2
NI - Nicaragua 2
PY - Paraguay 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UG - Uganda 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.340
Città #
Ashburn 264
Fairfield 222
Singapore 206
Hong Kong 134
Warsaw 134
Woodbridge 118
Chandler 91
Seattle 89
Houston 88
New York 85
Cambridge 84
Beijing 80
Helsinki 79
Jacksonville 79
Wilmington 76
Dallas 69
Munich 63
Princeton 58
Ann Arbor 44
Los Angeles 39
Brescia 34
Turku 33
Dublin 31
Istanbul 30
The Dalles 28
Ho Chi Minh City 23
São Paulo 23
Milan 21
San Francisco 20
Hanoi 19
Redondo Beach 19
Buffalo 18
Moscow 16
Des Moines 15
London 14
San Diego 13
Shanghai 13
Bergamo 12
Nanjing 12
Chicago 11
Denver 11
Johannesburg 11
Santa Clara 10
Changsha 9
Tokyo 9
Brooklyn 8
Montreal 8
Nanchang 8
Nuremberg 8
Salò 8
Stockholm 8
Vienna 7
Amsterdam 6
Atlanta 6
Belo Horizonte 6
Boardman 6
Brussels 6
Chennai 6
Ferrara 6
Orem 6
Shenyang 6
Vancouver 6
Albuquerque 5
Dhaka 5
Frankfurt am Main 5
Haikou 5
Jiaxing 5
Ningbo 5
Nürnberg 5
Rio de Janeiro 5
Baku 4
Bosio 4
Cairo 4
Council Bluffs 4
Dong Ket 4
Dosso 4
Guangzhou 4
Hebei 4
Jakarta 4
Jinan 4
Lappeenranta 4
Nairobi 4
Ninh Bình 4
Olomouc 4
Redwood City 4
Rivoli 4
Rome 4
Seoul 4
State College 4
Abu Dhabi 3
Amman 3
Baghdad 3
Bogotá 3
Campinas 3
Columbus 3
Duncan 3
Erbil 3
Falkenstein 3
Hải Dương 3
Mariano Comense 3
Totale 2.821
Nome #
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 323
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 180
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 176
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 175
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 170
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 167
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 160
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 158
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 154
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 148
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 146
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 146
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 144
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al 136
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 132
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 127
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 124
Pathophysiological role and therapeutic implications of vitamin d in autoimmunity: Focus on chronic autoimmune diseases 114
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 104
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system 103
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 98
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 98
A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis 92
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. 89
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies 87
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 82
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 78
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 77
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment 69
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 67
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 62
Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada 61
Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis 60
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 57
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases 56
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 54
Editorial: Into the heart of systemic autoimmune diseases. 51
Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases 50
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study 45
Totale 4.420
Categoria #
all - tutte 23.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021319 0 0 0 0 0 57 30 44 45 73 36 34
2021/2022321 26 24 9 29 3 26 14 17 15 51 44 63
2022/2023250 33 8 7 19 27 62 3 28 46 0 7 10
2023/2024419 23 11 57 44 22 82 12 63 60 6 2 37
2024/2025933 9 19 21 110 71 83 57 54 96 94 181 138
2025/20261.091 176 229 145 235 197 109 0 0 0 0 0 0
Totale 4.420